Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 176, Issue 3, Pages 1505-1516Publisher
ELSEVIER SCIENCE INC
DOI: 10.2353/ajpath.2010.090465
Keywords
-
Categories
Funding
- Cancer Council of Western Australia
- National Health and Medical Research Council (NHMRC) [458627, 572578]
- Cancer Council WA Fellowship
- K.B. Chandrashekar Research Foundation, India
- NHMRC [254504, 404002]
- NHMRC Career Development Award
- National Heart Foundation of Australia/NHMRC Postgraduate Research Scholarship
Ask authors/readers for more resources
Wnt signaling is involved in developmental processes, cell proliferation, and cell migration. Secreted frizzled-related protein 4 (sFRP4) has been demonstrated to be a Wnt antagonist; however, its effects on endothelial cell migration and angiogenesis have not yet been reported. Using various in vitro assays, we show that sFRP4 inhibits endothelial cell migration and the development of sprouts and pseudopodia as well as disrupts the stability of endothelial rings in addition to inhibiting proliferation. sFRP4 interfered with endothelial cell functions by antagonizing the canonical Wnt/beta-catenin signaling pathway and the Wnt/planar cell polarity pathway. Furthermore, sFRP4 blocked the effect of vascular endothelial growth factor on endothelial cells. sFRP4 also selectively induced apoptotic events in endothelial cells by increasing cellular levels of reactive oxygen species. In vivo assays demonstrated a reduction in vascularity after sFRP4 treatment. Most importantly, sFRP4 restricted tumor growth in mice by interfering with endothelial cell function. The data demonstrate SFRP4 to be a potent angiogenesis inhibitor that warrants further investigation as a therapeutic agent in the control of angiogenesis-associated pathology. (Am J Pathol 2010, 176:1505-1516; DOI: 10.2353/ajpath.2010.090465)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available